Chiesi Clinical Trial Site 840884 — Grants Pass, Oregon

Chiesi Clinical Trial Site 840884 is a clinical research site located in Grants Pass, Oregon, United States 97527.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Chiesi Clinical Trial Site 840884 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Chiesi Farmaceutici S.p.A..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grants Pass

Browse all research sites in Oregon · View every site in Grants Pass

• Three Rivers Community Hospital
• Velocity Clinical Research Grants Pass
• Research Site
• Velocity Clinical Research
• GSK Investigational Site
• Pfizer Investigational Site
• Teva Investigational Site 15646
• Kenji Hamada, OD
• Bausch Site 114
• Theravance Biopharma Investigational Site
• The Eye Care Group
• Orthopedic Center for Joint Replacement & Sports Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chiesi Clinical Trial Site 840884?

Chiesi Clinical Trial Site 840884 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chiesi Clinical Trial Site 840884 conducted?

Chiesi Clinical Trial Site 840884 has 1 clinical trials on record. Their work covers Asthma.

Is Chiesi Clinical Trial Site 840884 accredited by Crixeo Clinical Trials?

Chiesi Clinical Trial Site 840884 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chiesi Clinical Trial Site 840884?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.